Generex Announces Investor Conference Call-in Deta
Post# of 36537
(Total Views: 137)
Posted On: 01/14/2019 9:03:54 AM
Generex Announces Investor Conference Call-in Details; Management to Provide Update on Initiatives & Strategic Plans
9:00 AM ET, 01/14/2019 - GlobeNewswire
MIRAMAR, FL, Jan. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) (http://www.otcmarkets.com/stock/GNBT/quote), today announced the following access information for its investor conference call, to be hosted by President & Chief Executive Officer Joseph Moscato, and his management team Wednesday January 16, at 4:00 p.m. Eastern time:
Domestic US/Canada – 1-(866) 342-8588
Direct Toll / International - 1-(203) 518-9865
Conference ID - 85014
The purpose of the call is to update investors on the previously announced and pending acquisitions that offer significant value to the Generex parent company. Joseph Moscato, Generex President & Chief Executive Officer, will discuss the company’s financing plans related to the acquisitions, as well as the strategic focus of Generex for 2019 and beyond. Additional details and an agenda will be announced Tuesday, January 15th.
9:00 AM ET, 01/14/2019 - GlobeNewswire
MIRAMAR, FL, Jan. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) (http://www.otcmarkets.com/stock/GNBT/quote), today announced the following access information for its investor conference call, to be hosted by President & Chief Executive Officer Joseph Moscato, and his management team Wednesday January 16, at 4:00 p.m. Eastern time:
Domestic US/Canada – 1-(866) 342-8588
Direct Toll / International - 1-(203) 518-9865
Conference ID - 85014
The purpose of the call is to update investors on the previously announced and pending acquisitions that offer significant value to the Generex parent company. Joseph Moscato, Generex President & Chief Executive Officer, will discuss the company’s financing plans related to the acquisitions, as well as the strategic focus of Generex for 2019 and beyond. Additional details and an agenda will be announced Tuesday, January 15th.
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼